ILMN Q3 Earnings Top, '24 Sales View Down, Stock Dips in AftermarketZacks Investment Research • 11/05/24
Illumina (ILMN) Q3 Earnings: How Key Metrics Compare to Wall Street EstimatesZacks Investment Research • 11/05/24
Illumina to preview newest innovations in NGS and multiomic technologies at the American Society of Human Genetics Annual MeetingPRNewsWire • 10/31/24
What Analyst Projections for Key Metrics Reveal About Illumina (ILMN) Q3 EarningsZacks Investment Research • 10/30/24
Illumina's Q3 Earnings Coming Up: Time to Buy, Sell or Hold the Stock?Zacks Investment Research • 10/24/24
ILMN Stock Trading Near 52-Week High: Should You Buy, Sell or Hold?Zacks Investment Research • 10/18/24
Illumina introduces the MiSeq i100 Series: its simplest, fastest benchtop sequencersPRNewsWire • 10/09/24
Illumina to Announce Third Quarter 2024 Financial Results on Monday, November 4, 2024PRNewsWire • 10/07/24
Charles Dadswell to step down as General Counsel, Illumina initiates search for successorPRNewsWire • 10/03/24
GRAIL: Post-Spinoff, Illumina Maintains Control And Incentive To Support SuccessSeeking Alpha • 09/24/24
FDA Approves Illumina's TruSight Oncology Comprehensive Assay, Now Offered by PreCheck Health Services as "SolidTumorCheck+" -- A Breakthrough in Precision OncologyPRNewsWire • 09/09/24
Results of GRAIL's Galleri® Multi-Cancer Early Detection Blood Test in Prostate Cancer Published in JCO Precision OncologyPRNewsWire • 08/29/24